Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Panther Sports Nutrition
WARNING LETTER
•Panther Sports Nutrition•October 23, 2017

Panther Sports Nutrition – FDA Warning Letter, Oct 23, 2017

Record Details

The FDA issued a Warning Letter to Panther Sports Nutrition concerning its products "Ostarine MK2866" and "LGD MAX," marketed as dietary supplements. The FDA expressed significant safety concerns about these products, which contain Selective Androgen Receptor Modulators (SARMs), citing risks such as liver toxicity, heart attack, and stroke. The agency determined that these products do not meet the definition of a dietary supplement under section 201(ff) of the FD&C Act because their active ingredients, Ostarine and LGD-4033, were authorized for investigation as new drugs and were not marketed as supplements or food prior to this authorization (21 U.S.C. § 321(ff)(3)(B)(ii)). Consequently, the FDA classified "Ostarine MK2866" and "LGD MAX" as unapproved new drugs under section 201(p) of the FD&C Act, intended to affect body structure/function (muscle building) and not generally recognized as safe and effective. Furthermore, due to their potential for harmful effects, they are considered prescription drugs under section 503(b)(1)(A), requiring professional supervision. The firm's sale of these unapproved new drugs violates sections 301(d) and 505(a) of the FD&C Act. Additionally, the products are misbranded under section 502(f)(1) because their labeling lacks adequate directions for use, a requirement for prescription drugs. Introducing these misbranded products into interstate commerce violates section 301(a). Panther Sports Nutrition must promptly correct these violations within fifteen working days, providing a written response detailing corrective actions, recurrence prevention, and actions for distributed products, or face potential legal action including seizure and injunction.

Company
Panther Sports Nutrition
Inspection date
October 23, 2017
Product type
Drugs
Office
New Jersey District Office
Person
  • Diana Amador-Toro (District Director)
View Company Profile

ID · c60135a5-6739-4092-ab44-bcf5c1e48b2c

Violation Codes10
21 U.S.C. 321(ff)21 U.S.C. 321(ff)(3)(B)(ii)21 U.S.C. 321(g)(1)(C)21 U.S.C. 321(p)21 U.S.C. 353(b)(1)(A)21 U.S.C. 331(d)21.U.S.C. 355(a)21 U.S.C. 352(f)(1)21 U.S.C. 352(f)(2)FD&C Act 201(ff)

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Panther Sports Nutrition
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.